Fibrotic Cystic Lung Disease Post Hematopoietic Stem Cell Transplant: Who is the Culprit?
Walid AlamRayan MohamadMaysoun KoubaissiSalwa A KoubaissiPublished in: Clinical medicine insights. Case reports (2022)
Pulmonary complications post hematopoietic stem cell transplant (HSCT) are associated with poor outcomes and require extensive management depending on the etiology. They usually present in the form of bronchiolitis obliterans syndrome, interstitial pneumonitis, or drug toxicity that can lead to fibrosis. Scant data exists regarding diffuse cystic lung disease following HSCT, and the existing literature only mentions mild cystic changes. We present the case of a 25-year-old man with stage IVB Hodgkin's lymphoma post allogeneic HSCT, who developed progressive traction bronchiectasis, with the appearance of extensive pulmonary cysts that followed significant fibrotic changes and discuss the possible etiologies behind it.
Keyphrases
- hematopoietic stem cell
- pulmonary hypertension
- systemic sclerosis
- systematic review
- cystic fibrosis
- idiopathic pulmonary fibrosis
- multiple sclerosis
- diffuse large b cell lymphoma
- electronic health record
- oxidative stress
- risk factors
- type diabetes
- interstitial lung disease
- low dose
- big data
- metabolic syndrome
- bone marrow
- deep learning
- hodgkin lymphoma
- insulin resistance
- respiratory syncytial virus
- high grade
- data analysis